Discontinued Operations (Details Narrative) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Jun. 27, 2026
USD ($)
|
Jun. 27, 2026
USD ($)
|
Jun. 28, 2025
USD ($)
|
Jun. 27, 2026
USD ($)
|
Jun. 28, 2025
USD ($)
|
Dec. 28, 2022
Integer
|
|
| Soin Intangibles [Member] | ||||||
| Disposal Group, Including Discontinued Operations [Line Items] | ||||||
| Number of pending patents | Integer | 3 | |||||
| Amortize of intangible assets term | 10 years | |||||
| Discontinued Operations [Member] | Alyea Therapeutics Corporation [Member] | ||||||
| Disposal Group, Including Discontinued Operations [Line Items] | ||||||
| Depreciation | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Amortization | $ 1,000,000.0 | $ 500,000 | $ 1,000,000.0 | $ 1,100,000 | ||
| X | ||||||||||
- Definition Number of acquired intangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period remaining for amortization of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|